Author

Sankar Srinivasan

Observed names: S. Srinivasan, Srinivasan Sankar

Institution: Apollo Hospitals

Observed institutions: Apollo Hospitals, Chinese Academy of Medical Sciences & Peking Union Medical College, Sendai Kousei Hospital

OpenAlex ID: A5101306527

A Prospective, Molecular Epidemiology Study of EGFR Mutations in Asian Patients with Advanced Non–Small-Cell Lung Cancer of Adenocarcinoma Histology (PIONEER)

2014 · Yuankai Shi, Joseph Siu-Kie Au, et al. · Journal of Thoracic Oncology · 1,575

Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma

2024 · B. Sangro, S.L. Chan, et al. · Annals of Oncology · 379

Simultaneous Durvalumab and Platinum-Based Chemoradiotherapy in Unresectable Stage III Non–Small Cell Lung Cancer: The Phase III PACIFIC-2 Study

2025 · Jeffrey D. Bradley, Shunichi Sugawara, et al. · Journal of Clinical Oncology · 87

Molecular epidemiological prospective study of EGFR mutations from Asian patients (pts) with advanced lung adenocarcinoma (PIONEER).

2012 · Pan-Chyr Yang, Yuankai Shi, et al. · Journal of Clinical Oncology · 13

Diving deep for the needle in the haystack: An outbreak investigation of Burkholderia cenocepacia bacteremia

2024 · Abdul Ghafur, Praveen Balaguru, et al. · Infection Control and Hospital Epidemiology · 3

Pan-cancer analysis of the spectrum of homologous recombination DNA repair (HRR) pathway genes in the Indian population: A retrospective observational study

2023 · Nasreen Parween, Trisha Dutta Gupta, et al. · Cancer Research Statistics and Treatment · 3

Experience of Alk Mutation Testing in 3351 Indian Patients of Nsclc

2014 · S. Dutt, S.H. Advani, et al. · Annals of Oncology · 3

Efficacy of erlotinib as first-line maintenance therapy in patients with locally advanced or metastatic nonsmall cell lung cancer who have not experienced disease progression or unacceptable toxicity during chemotherapy

2017 · Senthil Rajappa, Dinesh Chandra Doval, et al. · South Asian Journal of Cancer · 2

Current Treatment Options for Human Epidermal Growth Factor Receptor 2-Directed Therapy in Metastatic Breast Cancer: An Indian Perspective

2018 · Gupta Sudeep, Chatterjee Sanjoy, et al. · Indian Journal of Medical and Paediatric Oncology · 1

WITHDRAWN: A Decade of Hereditary Cancer Genetic Testing Results in Asian Indian population: Retrospective Study

2026 · Ramesh Menon, Lakshmi Mahadevan, et al. · medRxiv

Predictive value of PET-CT and tumor biology for pathological complete response in triple-negative breast cancer treated with neoadjuvant pembrolizumab: A real-world analysis.

2026 · Niranjan Vijayaraghavan, Sankar Srinivasan, et al. · Journal of Clinical Oncology

Primary Mediastinal B-cell Lymphoma in Two Male Patients

2024 · Vyshnavi Rajeev, Gayathri Anur Ramakrishnan, et al. · Journal of Association of Pulmonologist of Tamil Nadu

Pioneer: A Prospective Molecular Epidemiological Study of EGFR Mutations in Asian Patients (Patients) with Advanced Lung Adenocarcinoma (ADC)

2012 · J.S.-K. Au, S. Yuankai, et al. · Annals of Oncology

Works count: 13

Citation count: 2,066

H-index: 4

I10-index: 4